A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

More Information

Trial Status
Accepting patients
Trial Phase
Phase 1
Enrollment
186 patients (estimated)
Sponsors
Orca Biosystems, Inc.
Tags
Allogeneic Stem Cell Transplant
Trial Type
Supportive
Last Update
2 months ago
SparkCures ID
1669
NCT Identifier
NCT03802695

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print this trial to share with your doctor.

We can help answer any questions and connect you (or your patient) with the study team.

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.